贝塔阻断剂和皮肤黑色素瘤结果:系统性审查和随机效应元分析
Nicholas M Muller1,2, Samuel X Tan1,2, Nisal Vipulaguna1
1Dermatology Research Centre, Frazer Institute, The University of Queensland, Brisbane, Australia.
贝塔阻断剂的使用可能会改善皮肤黑色素瘤患者的无病生存率,但证据不足以推治疗. 建议对泛选择性β-阻断剂进行进一步的研究,以了解潜在的益处.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 皮肤黑色素瘤是一个重大的公共卫生问题.
- 由于其低成本和安全性,β-阻断剂正在被探索为黑色素瘤的潜在辅助疗法.
- 目前关于β-阻断剂在黑色素瘤治疗中的疗效的证据仍然没有确定性.
结论:
- 目前的证据不足以支持在皮肤黑色素瘤治疗中常规使用β-阻断剂.
- 需要进一步的研究,特别是专注于泛选择性β抑制剂的特定作用.
- 澄清特定β抑制剂类型的作用可以为未来的治疗策略提供信息.
更多相关视频
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
相关概念视频
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers
Heart Failure Drugs: β-Blockers
Antihypertensive Drugs: Types of β-Blockers
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
